243 related articles for article (PubMed ID: 29289554)
1. Efficacy and Safety of On-Demand Use of 2 Treatments Designed for Different Etiologies of Female Sexual Interest/Arousal Disorder: 3 Randomized Clinical Trials.
Tuiten A; van Rooij K; Bloemers J; Eisenegger C; van Honk J; Kessels R; Kingsberg S; Derogatis LR; de Leede L; Gerritsen J; Koppeschaar HPF; Olivier B; Everaerd W; Frijlink HW; Höhle D; de Lange RPJ; Böcker KBE; Pfaus JG
J Sex Med; 2018 Feb; 15(2):201-216. PubMed ID: 29289554
[TBL] [Abstract][Full Text] [Related]
2. Genotype scores predict drug efficacy in subtypes of female sexual interest/arousal disorder: A double-blind, randomized, placebo-controlled cross-over trial.
Tuiten A; Michiels F; Böcker KB; Höhle D; van Honk J; de Lange RP; van Rooij K; Kessels R; Bloemers J; Gerritsen J; Janssen P; de Leede L; Meyer JJ; Everaerd W; Frijlink HW; Koppeschaar HP; Olivier B; Pfaus JG
Womens Health (Lond); 2018; 14():1745506518788970. PubMed ID: 30016917
[TBL] [Abstract][Full Text] [Related]
3. Two novel combined drug treatments for women with hypoactive sexual desire disorder.
Poels S; Bloemers J; van Rooij K; Koppeschaar H; Olivier B; Tuiten A
Pharmacol Biochem Behav; 2014 Jun; 121():71-9. PubMed ID: 24534417
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Food on the Pharmacokinetics of Sildenafil after Single Administration of a Sublingual Testosterone and Oral Sildenafil Combination Tablet in Healthy Female Subjects.
Bloemers J; Gerritsen J; van Rooij K; de Leede L; van der Geest R; Frijlink HW; Koppeschaar HPF; Olivier B; Tuiten A
J Sex Med; 2019 Sep; 16(9):1433-1443. PubMed ID: 31488289
[TBL] [Abstract][Full Text] [Related]
5. Toward personalized sexual medicine (part 3): testosterone combined with a Serotonin1A receptor agonist increases sexual satisfaction in women with HSDD and FSAD, and dysfunctional activation of sexual inhibitory mechanisms.
van Rooij K; Poels S; Bloemers J; Goldstein I; Gerritsen J; van Ham D; van Mameren F; Chivers M; Everaerd W; Koppeschaar H; Olivier B; Tuiten A
J Sex Med; 2013 Mar; 10(3):824-37. PubMed ID: 23130675
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial.
Davis S; Papalia MA; Norman RJ; O'Neill S; Redelman M; Williamson M; Stuckey BG; Wlodarczyk J; Gard'ner K; Humberstone A
Ann Intern Med; 2008 Apr; 148(8):569-77. PubMed ID: 18413618
[TBL] [Abstract][Full Text] [Related]
7. Psychometric Properties of the Sexual Event Diary in a Sample of Dutch Women With Female Sexual Interest/Arousal Disorder.
van Nes Y; Bloemers J; Kessels R; van der Heijden PGM; van Rooij K; Gerritsen J; DeRogatis L; Tuiten A
J Sex Med; 2018 May; 15(5):722-731. PubMed ID: 29699757
[TBL] [Abstract][Full Text] [Related]
8. Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cues.
Poels S; Bloemers J; van Rooij K; Goldstein I; Gerritsen J; van Ham D; van Mameren F; Chivers M; Everaerd W; Koppeschaar H; Olivier B; Tuiten A
J Sex Med; 2013 Mar; 10(3):810-23. PubMed ID: 23130748
[TBL] [Abstract][Full Text] [Related]
9. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.
Simon J; Braunstein G; Nachtigall L; Utian W; Katz M; Miller S; Waldbaum A; Bouchard C; Derzko C; Buch A; Rodenberg C; Lucas J; Davis S
J Clin Endocrinol Metab; 2005 Sep; 90(9):5226-33. PubMed ID: 16014407
[TBL] [Abstract][Full Text] [Related]
10. Partners Experience Consequences, Too: A Comparison of the Sexual, Relational, and Psychological Adjustment of Women with Sexual Interest/Arousal Disorder and Their Partners to Control Couples.
Rosen NO; Dubé JP; Corsini-Munt S; Muise A
J Sex Med; 2019 Jan; 16(1):83-95. PubMed ID: 30509505
[TBL] [Abstract][Full Text] [Related]
11. Advances in pharmacotherapy for treating female sexual dysfunction.
Nappi RE; Cucinella L
Expert Opin Pharmacother; 2015 Apr; 16(6):875-87. PubMed ID: 25732267
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study.
Berman JR; Berman LA; Toler SM; Gill J; Haughie S;
J Urol; 2003 Dec; 170(6 Pt 1):2333-8. PubMed ID: 14634409
[TBL] [Abstract][Full Text] [Related]
13. Dose-Finding Study of Lorexys for Hypoactive Sexual Desire Disorder in Premenopausal Women.
Pyke RE; Clayton AH
J Sex Med; 2019 Dec; 16(12):1885-1894. PubMed ID: 31678098
[TBL] [Abstract][Full Text] [Related]
14. Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA Study.
Portman DJ; Brown L; Yuan J; Kissling R; Kingsberg SA
J Sex Med; 2017 Jun; 14(6):834-842. PubMed ID: 28583342
[TBL] [Abstract][Full Text] [Related]
15. Systemic testosterone for the treatment of female sexual interest and arousal disorder (FSIAD) in the postmenopause.
Ribera Torres L; Anglès-Acedo S; López Chardi L; Mension Coll E; Castelo-Branco C
Gynecol Endocrinol; 2024 Dec; 40(1):2364220. PubMed ID: 38913119
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.
Kingsberg S; Shifren J; Wekselman K; Rodenberg C; Koochaki P; Derogatis L
J Sex Med; 2007 Jul; 4(4 Pt 1):1001-8. PubMed ID: 17627745
[TBL] [Abstract][Full Text] [Related]
17. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study.
Shifren JL; Davis SR; Moreau M; Waldbaum A; Bouchard C; DeRogatis L; Derzko C; Bearnson P; Kakos N; O'Neill S; Levine S; Wekselman K; Buch A; Rodenberg C; Kroll R
Menopause; 2006; 13(5):770-9. PubMed ID: 16932240
[TBL] [Abstract][Full Text] [Related]
18. Flibanserin for Premenopausal Hypoactive Sexual Desire Disorder: Pooled Analysis of Clinical Trials.
Simon JA; Thorp J; Millheiser L
J Womens Health (Larchmt); 2019 Jun; 28(6):769-777. PubMed ID: 30707049
[No Abstract] [Full Text] [Related]
19. Satisfying sexual events as outcome measures in clinical trial of female sexual dysfunction.
Kingsberg SA; Althof SE
J Sex Med; 2011 Dec; 8(12):3262-70. PubMed ID: 21883949
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of alprostadil cream for the treatment of female sexual arousal disorder: a double-blind, placebo-controlled study in chinese population.
Liao Q; Zhang M; Geng L; Wang X; Song X; Xia P; Lu T; Lu M; Liu V
J Sex Med; 2008 Aug; 5(8):1923-31. PubMed ID: 18564348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
